Meet an Unreasonable Venture
Vitargent
Award-winning biotechnology company enabling manufacturers to more ethically ensure their products are safe from harmful chemicals.
Notable Achievements
- Investors include PwC, G.E.M. (China's Taylor Swift)
- Owner of the world's largest biotoxicity & efficacy database on FMCGs
- Company with deep technologies recognized as one of the Technology Pioneers by World Economic Forum
Currently Operating in Seven Regions
Press Mentions
February 12, 2025
Hong Kong Needs Innovation Tech Talent Like You
Vitargent, a pioneering biotechnology company, is making significant strides in Hong Kong's innovation landscape. By developing advanced testing methods for environmental safety, Vitargent is...
Read on Dubaikhalifas »
December 10, 2021
Building Global Sustainability with the Power of Partnerships - SPONSOR CONTENT FROM UNREASONABLE IMPACT
Sponsor content from Unreasonable Impact.
Read on Harvard Business Review »
June 29, 2018
PwC Hong Kong signs investment agreement with biotech and internet platform company Vitargent
PwC Hong Kong ("PwC") has entered into an investment agreement today with Vitargent International Holdings Limited ("Vitargent"), a pioneer in bio-testing technology for product safety. This is...
Read on Cision »
February 2, 2018
Vitargent and PwC to accelerate product safety testing technologies
Vitargent (International) Biotechnology has become a strategic partner with PwC.
Read on foodqualitynews.com »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Vitargent and all of the other ventures working to solve global challenges.